Valuation: Lumos Diagnostics Holdings Limited

Market Cap 94.48M 65.67M 58.35M 54.46M 49.63M 93.61M 6.31B 659M 255M 3.23B 247M 241M 10.36B P/E 2027 *
-6.51x
P/E 2028 * -7.15x
Enterprise Value 81.86M 56.9M 50.55M 47.18M 43.01M 81.11M 5.47B 571M 221M 2.8B 214M 209M 8.97B EV / Sales 2027 *
2.88x
EV / Sales 2028 * 1.93x
Free-Float
81.23%
Yield 2027 *
-
Yield 2028 * -
1 week-4.76%
3 months-4.76%
6 months-52.38%
Current year-64.91%
1 week 0.1
Extreme 0.1
0.11
1 month 0.1
Extreme 0.098
0.12
Current year 0.08
Extreme 0.076
0.33
1 year 0.08
Extreme 0.076
0.33
3 years 0.02
Extreme 0.019
0.33
5 years 0.01
Extreme 0.01
1.26
10 years 0.01
Extreme 0.01
1.5
Manager TitleAgeSince
Chief Executive Officer - 2022-06-20
Director of Finance/CFO - 2022-02-15
Chief Operating Officer - -
Director TitleAgeSince
Chairman - 2018-12-31
Director/Board Member 59 2020-10-31
Director/Board Member - 2020-10-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26 Buy

Chief Executive Officer

202,131 0.0214%
7/24/26 Exercice

Chief Executive Officer

4,166,752 0.4412%
6/2/26 Exercice

Chief Executive Officer

3,706,331 0.3989%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.76%-33.33%+3.09% 65.67M
+0.84%-3.74%-27.56%+1.93% 169B
-0.07%-2.55%-11.59%+13.26% 110B
+0.90%+1.13%-25.66%+3.47% 106B
+1.47%-0.82%-47.52%-11.10% 73.87B
-0.24%+0.69%+2.08%+69.19% 58.98B
+1.32%+3.86%+8.58%+61.88% 51.28B
-0.71%-3.82%-8.68%-31.93% 48.16B
+0.12%-0.17%-17.87%+19.66% 40.84B
-1.01%-1.45%+27.31%-2.67% 32.21B
Average +0.05%-1.68%-13.42%+12.68% 69.03B
Weighted average by Cap. +0.06%-1.30%-17.18%+11.26%

Financials

2027 *2028 *
Net sales 28.46M 19.78M 17.58M 16.41M 14.95M 28.2M 1.9B 199M 76.94M 972M 74.28M 72.67M 3.12B 38.12M 26.49M 23.54M 21.97M 20.02M 37.76M 2.55B 266M 103M 1.3B 99.46M 97.3M 4.18B
Net income -13.98M -9.72M -8.63M -8.06M -7.34M -13.85M -934M -97.5M -37.78M -477M -36.48M -35.68M -1.53B -11.25M -7.82M -6.95M -6.48M -5.91M -11.15M -752M -78.47M -30.41M -384M -29.36M -28.72M -1.23B
Net Debt -12.62M -8.77M -7.79M -7.27M -6.63M -12.5M -843M -88.01M -34.1M -431M -32.93M -32.21M -1.38B -21.03M -14.62M -12.99M -12.12M -11.05M -20.84M -1.41B -147M -56.84M -718M -54.88M -53.69M -2.31B
Logo Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a threein-one point-of-care test for influenza A, influenza B and COVID-19. The Company manages the full development program for POC assays.
Employees
-
Date Price Change Volume
26-10-05 A$0.1000 0.00% 89,931
26-10-02 A$0.1000 0.00% 1,231,542
26-10-01 A$0.1000 0.00% 894,169
26-09-30 A$0.1000 -4.76% 680,723
26-09-29 A$0.1050 0.00% 1,088,450
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1000AUD
Average target price
0.3000AUD
Spread / Average Target
+200.00%

Quarterly revenue - Rate of surprise